Skip to NavigationSkip to content

News

0
Liquid biopsy company, Angle, has announced results from their study in non-small cell lung cancer (NSCLC) which demonstrates the benefit of...
0
Artificial intelligence firm Behold.ai has won a share of £140 million in government funding for its red dot lung cancer detection platform, as part...
0
Australia will now only recommend that people over 60 receive the AstraZeneca vaccine due to the rare occurrence of post-jab blood clots.
0
Scientists have announced the identification of a new class of cancer drugs, known as POLQ inhibitors, that specifically kill cancer cells with...

Features

It’s been 15 years since the first biosimilar entered the market, and the impact of these drugs on the healthcare industry has been immense. Now...